Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

ST. VINCENT JENNINGS HOSPITAL, INC.

NPI: 1285684829 · NORTH VERNON, IN 47265 · Critical Access Hospital · NPI assigned 05/12/2006

$4.33M
Total Medicaid Paid
119,894
Total Claims
96,195
Beneficiaries
61
Codes Billed
2018-01
First Month
2024-11
Last Month

Provider Details

Authorized OfficialROCHE, JOSEPH (ADMINISTRATOR)
NPI Enumeration Date05/12/2006

Related Entities

Other providers sharing the same authorized official: ROCHE, JOSEPH

ProviderCityStateTotal Paid
DERMATOLOGY GROUP OF THE CAROLINAS CONCORD NC $1.85M

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 14,273 $134K
2019 9,318 $142K
2020 13,752 $510K
2021 19,989 $876K
2022 25,849 $1.09M
2023 22,217 $989K
2024 14,496 $583K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99283 Emergency department visit for the evaluation and management, moderate severity 10,779 9,429 $1.63M
99284 Emergency department visit for the evaluation and management, high severity 8,140 6,388 $859K
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 4,051 3,336 $392K
71045 Radiologic examination, chest; single view 2,958 2,315 $356K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 2,831 2,164 $136K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 2,353 1,892 $136K
80053 Comprehensive metabolic panel 18,353 15,068 $110K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 20,165 16,042 $90K
71046 Radiologic examination, chest; 2 views 451 387 $78K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 1,143 982 $77K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1,888 1,648 $75K
99282 Emergency department visit for the evaluation and management, low to moderate severity 433 388 $59K
36415 Collection of venous blood by venipuncture 17,878 14,832 $43K
84443 Thyroid stimulating hormone (TSH) 4,378 3,832 $41K
96361 Intravenous infusion, hydration; each additional hour 277 207 $35K
80061 Lipid panel 4,189 3,679 $34K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 579 456 $31K
90853 Group psychotherapy (other than of a multiple-family group) 3,857 652 $18K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 695 602 $13K
87634 178 165 $11K
84484 1,163 872 $9K
83036 Hemoglobin; glycosylated (A1C) 1,318 1,147 $8K
82607 836 710 $8K
82746 824 701 $7K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 109 100 $7K
81001 2,964 2,381 $6K
83655 443 428 $6K
96375 Therapeutic injection; each additional sequential IV push 787 562 $5K
86803 451 401 $5K
87081 744 710 $5K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 57 14 $4K
71271 19 16 $4K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 238 187 $4K
70450 Computed tomography, head or brain; without contrast material 30 26 $4K
80048 Basic metabolic panel (calcium, ionized) 690 517 $3K
80306 308 233 $3K
83540 555 475 $2K
83690 502 397 $2K
83605 267 213 $2K
82728 138 125 $1K
83550 192 179 $1K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 94 79 $829.84
82570 207 188 $594.96
82043 186 171 $570.01
81025 76 63 $518.92
83735 94 78 $516.19
84439 95 72 $516.00
87086 Culture, bacterial; quantitative colony count, urine 146 117 $461.82
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 36 30 $440.85
86140 153 127 $423.34
87088 71 61 $288.09
87070 29 28 $232.74
82553 114 71 $189.12
80076 37 29 $184.71
82550 112 72 $183.03
85610 47 40 $115.83
90791 Psychiatric diagnostic evaluation 14 12 $49.80
85652 30 25 $26.29
J2405 Injection, ondansetron hydrochloride, per 1 mg 13 12 $0.00
A9270 Non-covered item or service 97 50 $0.00
J1885 Injection, ketorolac tromethamine, per 15 mg 32 12 $0.00